Page last updated: 2024-09-04

pumosetrag and Pyrosis

pumosetrag has been researched along with Pyrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choung, RS; Crowell, MD; Devault, K; Francis, DD; Harmsen, WS; Katzka, D; Locke, GR; Orr, WC; Talley, NJ; Winkle, PJ; Zinsmeister, AR	1

Trials

1 trial(s) available for pumosetrag and Pyrosis

Article	Year
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study. Neurogastroenterology and motility, 2014, Volume: 26, Issue:1 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Partial Agonism; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Meals; Middle Aged; Pyridines; Quinuclidines; Serotonin 5-HT3 Receptor Agonists; Young Adult	2014

Article

Year

Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study.

Neurogastroenterology and motility, 2014, Volume: 26, Issue:1

Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Partial Agonism; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Meals; Middle Aged; Pyridines; Quinuclidines; Serotonin 5-HT3 Receptor Agonists; Young Adult

2014